Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 14,182 | 28,866 | 1,262 | 26,554 | 1,750 |
| Cost of Goods | 10 | 33 | 30 | 348 | 71 |
| Gross Profit | 14,172 | 28,833 | 1,232 | 26,206 | 1,679 |
| Operating Expenses | 26,369 | 25,130 | 26,941 | 59,291 | 65,443 |
| Operating Income | -12,187 | 3,736 | -25,679 | -32,737 | -63,693 |
| Interest Expense | 2,155 | 2,318 | 1,835 | 3,858 | 4,562 |
| Other Income | 1,573 | 1,834 | 2,219 | 2,829 | 3,444 |
| Pre-tax Income | -12,769 | 3,252 | -25,295 | -33,766 | -64,811 |
| Net Income Continuous | -12,769 | 3,252 | -25,295 | -33,766 | -64,811 |
| Net Income | $-12,769 | $3,252 | $-25,295 | $-33,766 | $-64,811 |
| EPS Basic Total Ops | -0.04 | 0.01 | -0.07 | -0.08 | -0.18 |
| EPS Basic Continuous Ops | -0.04 | 0.01 | -0.07 | -0.08 | -0.18 |
| EPS Diluted Total Ops | -0.04 | 0.01 | -0.07 | -0.08 | -0.18 |
| EPS Diluted Continuous Ops | -0.04 | 0.01 | -0.07 | -0.08 | -0.18 |
| EPS Diluted Before Non-Recurring Items | -0.04 | 0.01 | -0.07 | -0.09 | -0.18 |
| EBITDA(a) | $-11,634 | $4,314 | $-25,102 | $-32,211 | $-63,165 |